Skip to main content

Research

Investable indexes: August 2010 returns

The May 2010 returns for investable indexes including the Dow Jones Credit Suisse Hedge Fund Index, Frontier Capital Multi Asset Platform Fund versus the indexes, Hedge Fund Research Indexes and Lyxor Alternative Index.

Risk Australia Rankings 2009: The debt dividend

Following a major sell-off in the second half of last year, the antipodean financial markets are seeing significant inflows of foreign capital in 2009 due to the resilience of the Australian economy. Dealers are also profiting from derivatives activity…

Investable indexes: June 2010 returns

The June2010 returns for investable indexes including Dow JonesCredit Suisse Hedge Fund Index, Frontier Capital Multi Asset Platform Fund, Hedge Fund Research Indexes and Lyxor Alternative Index.

Investable indexes: May 2010 returns

The May 2010 returns for investable indexes including Credit Suisse/Tremont Hedge Fund Index, Dow Jones Investable Indexes, Frontier Capital Multi Asset Platform Fund versus the indexes, Hedge Fund Research Indexes and Lyxor Alternative Index.

Risk institutional investor rankings 2010

The resurgence of market volatility and growing regulatory uncertainty have made the past 12 months challenging for investors. In this difficult environment, respondents to Risk’s institutional investor survey voted JP Morgan the top provider of…

Investable indexes: April 2010 returns

The April 2010 returns for investable indexes, including Credit Suisse/Tremont Hedge Fund Index, Dow Jones Investable Indexes, Frontier Capital Multi Asset Platform Fund versus the indexes, Hedge Fund Research Indexes and Lyxor Alternative Index.

Compliance vendors triumph in adversity

Compliance providers have found new customers as a result of the recently changed regulatory environment, while adopting integrated approaches to make the best of tightened budgets everywhere. David Benyon reports

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here